One Drop, a digital blood glucose monitoring kit for diabetes management will now be available in select retail Apple stores, CNBC reports. Currently sold online in the Apple Store for $69.95, the digital diabetes kit includes a Bluetooth glucose meter, test strips, lancets (optional), and one year of free coaching from a certified diabetes coach.One Drop Blood Glucose MonitorOne Drop’s blood glucose meter ensures clinically proven accurate, reliable results in just five seconds. The meter then
Read More
Impact of Diabetes Management for Patients, Payers, and Providers| News, Policy, Analysis, Insights - HIT Consultant
Livongo Announces Bi-directional Integration with Apple, Fitbit, Samsung Smartwatches
Livongo, a leading Applied Health Signals company empowering people with chronic conditions, today announced the launch of a bi-directional integration with the top smartwatches in the market, including leading models from Apple, Fitbit, and Samsung. Livongo Members can now connect their smartwatches to the Livongo mobile app to receive real-time Livongo notifications on the surface of their choice enabling Livongo to provide more timely and relevant information to Members and their care
Read More
Research: Livongo for Diabetes Program Improved Diabetes Distress Levels
Livongo, an Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the findings of a study conducted in collaboration with Eli Lilly and Company that demonstrated 94 percent of Livongo program Members who participated in a program survey achieved improved Diabetes Empowerment Scale-Short Form (DES-SF) or Diabetes Distress Scale 2 (DDS2) in year one. The research findings were presented on June 8, 2019, at the American Diabetes
Read More
Companion Medical Integrates Smart Insulin Pen with Rimidi Diabetes Management App
Rimidi and Companion Medical announced a first-of-its-kind partnership to enhance data visualization for clinicians treating high-risk patients with diabetes who are on insulin therapy. The collaboration integrates Companion Medical’s connected device, InPen™, the first and only FDA-cleared, smart insulin pen paired with an integrated diabetes management app, into Rimidi’s platform by pushing insulin dosing data from the InPen through the cloud.Integration BenefitsThis partnership reduces the
Read More
Glooko Integrates Insulin Data with Companion Medical’s Smart Insulin Injection Pen
Glooko and Companion Medical have announced an integrated data partnership agreement that will enable insulin data from users of the InPen Smart Insulin Injection Pen to be integrated into the Glooko Enterprise diabetes data management system and Glooko Mobile App.
Impact of Integration
The announcement of this integration is significant because InPen is the first “smart” insulin pen to introduce its data integration and compatibility with the Glooko platform
Read More
Glooko Appoints Dr. Mark Clements as Chief Medical Officer
Glooko, a provider of diabetes data management solutions, today announced the appointment of Mark Clements, MD, Ph.D., CPI, FAAP, as Chief Medical Officer. Dr. Clements joins the senior management team of Glooko having served on its medical advisory board since it was formed in 2015 to provide expertise to the organization in the areas of clinical studies and diabetes analytics.
Dr. Clements comes to Glooko from the University of Missouri-Kansas City School of Medicine, where he is Associate
Read More
Solera Health Raises $42M to Scale Integrated Benefit Network for Chronic Disease Prevention
Solera Health, a Phoenix, AZ-based technology-enabled integrated benefit network has raised $42 million in Series C funding led by HCSC Ventures. Current investors BlueCross BlueShield Venture Partners/Sandbox Advantage Fund, Adams Street Partners and SJF Ventures also participated in the most recent funding round. The Series C round, Solera's largest to date, brings its total funding to $72 million.Integrated Benefit NetworkFounded in 2015, Solera Health serves as an integrated benefit network
Read More
Livongo for Diabetes Program Reduced Medical Spending by 22% for Members, Study Finds
The Livongo for Diabetes program delivered a 21.9 percent reduction in medical spending for Livongo members when compared to the matched non-Livongo population, according to study findings published in the latest edition of the Journal of Medical Economics. When taking the average price of the Livongo for Diabetes program into account, the study demonstrated that employers experienced a positive return on investment in one year.Financial Impact of Diabetes Management in the U.S.Diabetes is one
Read More
CHLA Announces 10 Semi-Finalists from Gamifying Pediatrics Hackathon
The Innovation Studio at Children’s Hospital Los Angeles (CHLA), today announced10 semi-finalists from the first ever Gamifying Pediatrics Hackathon, which took place April 12-14, 2019 at BCG Digital Ventures (BCGDV) in Manhattan Beach (CA), the global corporate venture and incubation arm of the Boston Consulting Group. This hackathon brought together 185 enthusiastic participants, including physicians and nurses on the front lines of pediatric medicine, engineers, developers, and experts in
Read More
Livongo Adds HIPAA-Compliant Amazon Alexa Healthcare Skill for Diabetes
Livongo, the leading Applied Health Signals company, today announced the Livongo for Diabetes program will now leverage Amazon Alexa's voice service to offer its Members the ability to ask any of their Alexa-enabled devices to provide their blood glucose readings and health tips via the new Livongo skill. The integration marks Livongo as the first consumer digital health company to collaborate with Amazon Alexa on a new HIPAA-compliant healthcare skill, which builds on Livongo's efforts to make
Read More
